quadrivalent recombinant influenza vaccine (Sanofi Pasteur)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namequadrivalent recombinant influenza vaccine (Sanofi Pasteur)

Drug Alias NameQuadrivalent RIV with H3 strain 2 (Sanofi Pasteur)Quadrivalent RIV with H3 strain 4 (Sanofi Pasteur)quadrivalent recombinant influenza vaccine with H3 strain 1 (Sanofi Pasteur)Quadrivalent RIV with H3 strain 3 (Sanofi Pasteur)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi Pasteur Sa

China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur Sa

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A